McKesson Corporation $MCK is Zuckerman Investment Group LLC's 5th Largest Position

Key Points

• Zuckerman Investment Group trimmed its McKesson stake by 5.3% to 47,278 shares, leaving the position valued at $36.53 million and representing 3.4% of the fund (its 5th largest holding).
• Corporate insiders sold 3,868 shares worth about $3.74 million in the last quarter — including EVP Michele Lau's 2,725-share sale (a 45.63% reduction) — and insiders now own just 0.08% of McKesson stock.
• McKesson beat quarterly estimates with $9.34 EPS vs. $9.19 expected and $106.16 billion in revenue (up 11.4% YoY), set FY2026 guidance of $38.80–$39.20 EPS, declared a $0.82 quarterly dividend ($3.28 annual), and carries a consensus "Moderate Buy" with an average target around $961.

Zuckerman Investment Group LLC lessened its position in shares of McKesson Corporation (NYSE:MCK - Free Report) by 5.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 47,278 shares of the company's stock after selling 2,630 shares during the period. McKesson accounts for 3.4% of Zuckerman Investment Group LLC's investment portfolio, making the stock its 5th largest position. Zuckerman Investment Group LLC's holdings in McKesson were worth $36,525,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Obsidian Personal Planning Solutions LLC increased its holdings in McKesson by 2.9% in the 3rd quarter. Obsidian Personal Planning Solutions LLC now owns 426 shares of the company's stock worth $346,000 after acquiring an additional 12 shares during the last quarter. IAM Advisory LLC lifted its holdings in McKesson by 0.3% during the third quarter. IAM Advisory LLC now owns 3,908 shares of the company's stock valued at $3,019,000 after purchasing an additional 13 shares during the last quarter. PDS Planning Inc boosted its position in McKesson by 1.1% during the third quarter. PDS Planning Inc now owns 1,209 shares of the company's stock worth $934,000 after purchasing an additional 13 shares during the period. Berkshire Asset Management LLC PA boosted its position in McKesson by 4.6% during the third quarter. Berkshire Asset Management LLC PA now owns 294 shares of the company's stock worth $227,000 after purchasing an additional 13 shares during the period. Finally, Goldstein Advisors LLC increased its stake in shares of McKesson by 4.4% in the third quarter. Goldstein Advisors LLC now owns 334 shares of the company's stock worth $258,000 after purchasing an additional 14 shares in the last quarter. Institutional investors own 85.07% of the company's stock.

Insider Transactions at McKesson

In related news, EVP Leann B. Smith sold 190 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the sale, the executive vice president owned 2,989 shares in the company, valued at approximately $2,824,605. This trade represents a 5.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Michele Lau sold 2,725 shares of McKesson stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total value of $2,697,750.00. Following the sale, the executive vice president directly owned 3,247 shares of the company's stock, valued at $3,214,530. This represents a 45.63% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 3,868 shares of company stock valued at $3,743,820. Corporate insiders own 0.08% of the company's stock.

McKesson Trading Down 0.3%

Shares of McKesson stock opened at $941.51 on Friday. The company's 50-day moving average price is $893.90 and its 200-day moving average price is $824.34. McKesson Corporation has a 12-month low of $637.00 and a 12-month high of $999.00. The company has a market cap of $115.33 billion, a price-to-earnings ratio of 27.08, a PEG ratio of 1.52 and a beta of 0.38.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company had revenue of $106.16 billion during the quarter, compared to analysts' expectations of $105.98 billion. During the same quarter in the previous year, the company earned $8.03 earnings per share. McKesson's revenue for the quarter was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, sell-side analysts predict that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be given a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Monday, March 2nd. McKesson's payout ratio is 9.43%.

Analysts Set New Price Targets

Several research firms have recently issued reports on MCK. Raymond James Financial set a $970.00 price target on shares of McKesson in a research report on Thursday, March 5th. Robert W. Baird set a $968.00 price objective on shares of McKesson in a research note on Wednesday, January 14th. TD Cowen boosted their target price on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a "buy" rating in a report on Thursday, February 5th. JPMorgan Chase & Co. increased their target price on McKesson from $983.00 to $1,107.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 10th. Finally, Wells Fargo & Company raised their price target on McKesson from $914.00 to $925.00 and gave the stock an "equal weight" rating in a report on Thursday, February 5th. Thirteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, McKesson has a consensus rating of "Moderate Buy" and an average target price of $960.93.

McKesson Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.